PYLERA® Capsules (bismuth subcitrate potassium, metronidazole, and tetracycline hydrochloride), in combination with omeprazole, are indicated for the treatment of patients with Helicobacter pylori (H.
BRIDGEWATER, NJ--(Marketwired - Apr 11, 2013) - Aptalis Pharma, US Inc. announced that its French sister company, Aptalis Pharma SAS, has launched PYLERA ® to healthcare professionals in France.
Par, an Endo company, is offering the first generic version of Allergan's Pylera (bismuth subcitrate potassium, metronidazole, tetracycline hydrochloride) 40 mg, 125 mg and 125 mg capsules. "We're ...
BRIDGEWATER, N.J. — Aptalis Pharma has launched its 10-day drug therapy for treating a gastrointestinal bacterial infection and ulcer condition, the company said. Aptalis announced the launch of ...
Endo International plc announced that one of its operating companies, Par Pharmaceutical, Inc., has begun shipping the first generic version of Allergan's Pylera (bismuth subcitrate potassium, ...
> Axcan Pharma has released the results of its European PYLERA® Phase III trial comparing the rate of Helicobacter pylori (H. pylori) eradication after OBMT (Omeprazole, Bismuth Subcitrate Potassium, ...
SAN FRANCISCO (MarketWatch) -- Axcan Pharma Inc. said Friday the Food and Drug Administration has approved its new drug application for Pylera, formerly Helizide. Pylera treats the bacterium ...
DUBLIN, March 10, 2023 /PRNewswire/ -- Endo International plc (OTC: ENDPQ) announced today that one of its operating companies, Par Pharmaceutical, Inc., has begun shipping the first generic version ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results